Five Telling Takeways from Benzinga Psychedelics Capital Conference
Join our Newsletter (scroll to the bottom of the page and sign up):
Follow us on Twitter:
Psychedelic Spotlight: @PsycSpotlight
Follow us on Instagram:
@psycspotlight
The first ever Benzinga Psychedelics Capital Conference was held on April 19 at the Fontainbleau Hotel in Miami Beach. It preceded the 14th iteration of the Cannabis Capital Conference and represented a return to form for Benzinga after years lost to pandemic pandemonium.
The conference brought together leaders of the biggest publicly traded psychedelics companies with investors from across North America. It was a day full of unique networking opportunities, insight on opportunities in this burgeoning space, and a chance to be in the room with the leaders who are endeavoring to take the psychedelics industry to the next level.
Psychedelic Spotlight had the opportunity to attend, so I wanted to share five telling takeaways from the Benzinga Psychedelics Capital Conference scene.
1. Expect Another Benzinga Psychedelics Capital Conference in 2023
2. Irwin Naturals Affirms Its ‘First Mover Advantage’
3. Innovators From Other Sectors Seek Psychedelic Synergy
4. Women Have an Advocate in Felicity Pharma CEO Olivia Mannix
5. Super Mario Was Way Ahead of His Time
#psychedelics #benzinga #psychedelicstocks
source
![MindMed Patents 18MC? A new Psychedelic ETF? [ Plus more MMED/MMEDF, LOBE, CYBIN & COOL Updates]](https://psychedelicspotlight.com/wp-content/uploads/2022/06/maxresdefault-88-600x338.jpeg)
